X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (66044) 66044
Newsletter (7458) 7458
Newspaper Article (2902) 2902
Magazine Article (296) 296
Book Chapter (221) 221
Transcript (164) 164
Book / eBook (73) 73
Reference (52) 52
Dissertation (48) 48
Publication (46) 46
Web Resource (34) 34
Streaming Video (9) 9
Book Review (8) 8
Conference Proceeding (8) 8
Journal / eJournal (4) 4
Paper (4) 4
Government Document (3) 3
Trade Publication Article (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (47838) 47838
male (26645) 26645
female (25457) 25457
non-hodgkin's lymphomas (22275) 22275
middle aged (21072) 21072
adult (18858) 18858
oncology (16986) 16986
aged (16805) 16805
non-hodgkins-lymphoma (14191) 14191
cancer (13015) 13015
hematology (11824) 11824
lymphoma, non-hodgkin - pathology (9398) 9398
lymphomas (8980) 8980
research (8818) 8818
lymphoma (8776) 8776
chemotherapy (8645) 8645
prognosis (7644) 7644
adolescent (7631) 7631
t cells (7494) 7494
lymphoma, non-hodgkin - drug therapy (7035) 7035
care and treatment (6884) 6884
antineoplastic combined chemotherapy protocols - therapeutic use (6549) 6549
animals (6270) 6270
aged, 80 and over (5907) 5907
non-hodgkin's lymphoma (5593) 5593
treatment outcome (5304) 5304
child (5189) 5189
lymphoma, non-hodgkin - therapy (4644) 4644
retrospective studies (4603) 4603
rituximab (4453) 4453
leukemia (4452) 4452
lymphoma, non-hodgkin - diagnosis (4408) 4408
risk factors (4369) 4369
pathology (4177) 4177
b-cell lymphoma (3834) 3834
health aspects (3764) 3764
non-hodgkin lymphoma (3743) 3743
diagnosis (3740) 3740
transplantation (3492) 3492
therapy (3479) 3479
analysis (3472) 3472
lymphoma, non-hodgkin - complications (3342) 3342
non-hodgkin-lymphoma (3211) 3211
disease (3192) 3192
neoplasm staging (3148) 3148
combined modality therapy (3100) 3100
immunohistochemistry (3049) 3049
lymphoma, non-hodgkin (3048) 3048
medical research (3046) 3046
diagnosis, differential (3037) 3037
child, preschool (2988) 2988
antineoplastic agents - therapeutic use (2897) 2897
hemic and lymphatic diseases (2882) 2882
mice (2830) 2830
tumors (2807) 2807
immunology (2789) 2789
survival (2784) 2784
lymphoma, non-hodgkin - immunology (2742) 2742
expression (2738) 2738
cyclophosphamide - administration & dosage (2692) 2692
follow-up studies (2670) 2670
drug therapy (2634) 2634
lymphoma, non-hodgkin - mortality (2629) 2629
survival rate (2562) 2562
medicine, experimental (2561) 2561
medicine & public health (2522) 2522
young adult (2462) 2462
survival analysis (2424) 2424
lymphoma, non-hodgkin - genetics (2405) 2405
medicine, general & internal (2369) 2369
genetic aspects (2364) 2364
follicular lymphoma (2353) 2353
neoplasms (2350) 2350
disease-free survival (2347) 2347
lymphoma, non-hodgkin - epidemiology (2337) 2337
vincristine - administration & dosage (2318) 2318
biopsy (2283) 2283
risk (2279) 2279
malignant-lymphoma (2219) 2219
lymphoma, large b-cell, diffuse - pathology (2190) 2190
chronic lymphocytic-leukemia (2176) 2176
classification (2150) 2150
doxorubicin - administration & dosage (2136) 2136
radiology, nuclear medicine & medical imaging (2096) 2096
antineoplastic agents (2079) 2079
time factors (2076) 2076
radiotherapy (2059) 2059
physical fitness (1993) 1993
immunotherapy (1974) 1974
apoptosis (1938) 1938
lymphoma, non-hodgkin - radiotherapy (1931) 1931
remission induction (1897) 1897
prednisone - administration & dosage (1877) 1877
surgery (1877) 1877
lymphoma - pathology (1875) 1875
tomography, x-ray computed (1860) 1860
antimitotic agents (1855) 1855
antineoplastic combined chemotherapy protocols - administration & dosage (1854) 1854
epidemiology (1851) 1851
lymphoma, b-cell - pathology (1838) 1838
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (32) 32
Online Resources - Online (12) 12
Collection Dvlpm't (Acquisitions) - Vendor file (10) 10
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (9) 9
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Robarts - Stacks (2) 2
Scarborough Hospital - General (1) 1
Toronto East General Hospital - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (71303) 71303
Russian (1214) 1214
Japanese (1110) 1110
French (1026) 1026
German (961) 961
Chinese (582) 582
Spanish (555) 555
Polish (433) 433
Italian (311) 311
Hungarian (114) 114
Czech (112) 112
Korean (100) 100
Portuguese (66) 66
Dutch (44) 44
Bulgarian (42) 42
Croatian (36) 36
Serbian (28) 28
Finnish (25) 25
Turkish (25) 25
Romanian (23) 23
Hebrew (22) 22
Danish (21) 21
Norwegian (18) 18
Slovak (15) 15
Persian (9) 9
Ukrainian (8) 8
Greek (7) 7
Lithuanian (7) 7
Slovenian (3) 3
Afrikaans (2) 2
Bosnian (2) 2
Arabic (1) 1
Galician (1) 1
Indonesian (1) 1
Manx (1) 1
Swedish (1) 1
Thai (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2009, 2nd ed., ISBN 9780781791168, xiv, 597
Book
2004, ISBN 9780781735261, xix, 856
Book
1997, 2nd ed., ISBN 0340557931, xvi, 1149
Book
1990, ISBN 0713145447, xvi, 430
Book
Leukemia & lymphoma, ISSN 1042-8194, 1989
Journal
Primary Care - Clinics in Office Practice, ISSN 0095-4543, 12/2016, Volume 43, Issue 4, pp. 661 - 675
Journal Article
Clinical cancer research, ISSN 1557-3265, 2017, Volume 23, Issue 15, pp. 4212 - 4223
Purpose: Patients with B-cell lymphomas often relapse after frontline therapy, and novel therapies are urgently needed to provide long-term remission... 
ONCOLOGY | RITUXIMAB | BONE-MARROW | INVOLVEMENT | IBRUTINIB | RESISTANCE | NON-HODGKIN-LYMPHOMA | CANCER | CHEMOTHERAPY | TRANSPLANTATION | FEATURES | Lymphoma, Follicular - drug therapy | Humans | Lymphoma, Mantle-Cell - pathology | Protein Kinase Inhibitors - adverse effects | Burkitt Lymphoma - pathology | Protein-Tyrosine Kinases - genetics | Lymphoma, Follicular - genetics | Burkitt Lymphoma - genetics | Lymphoma, B-Cell, Marginal Zone - pathology | Gene Expression Regulation, Neoplastic - drug effects | Lymphoma, Mantle-Cell - genetics | Burkitt Lymphoma - drug therapy | Disease Models, Animal | Precision Medicine | Pyrazoles - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Follicular - pathology | Pyrimidines - administration & dosage | Lymphoma, Mantle-Cell - drug therapy | Drug Discovery | Lymphoma, B-Cell, Marginal Zone - genetics | Phosphatidylinositol 3-Kinases - genetics | Xenograft Model Antitumor Assays | Protein Kinase Inhibitors - administration & dosage | Drug Resistance, Neoplasm - genetics | Pyrazoles - administration & dosage | Animals | Signal Transduction - drug effects | Lymphoma, B-Cell, Marginal Zone - drug therapy | Lymphoma, Large B-Cell, Diffuse - classification | Pyrimidines - adverse effects | Mice | Lymphoma, Large B-Cell, Diffuse - genetics | Cell culture | Therapy | Animal models | Kinases | Inactivation | Signal transduction | Biological effects | Peripheral blood | Xenografts | Remission | Protein-tyrosine kinase | Tyrosine | Deactivation | Tumor cells | Patients | Lymphoma | 1-Phosphatidylinositol 3-kinase | Burkitt's lymphoma | Signaling | Inhibitors | Lymphocytes B | Experimental design | Mantle cell lymphoma | Lymphomas | Mutation | Tumors | Cancer | B-cell lymphoma | patient-derived xenograft | personalized therapy
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2012, Volume 379, Issue 9822, pp. 1234 - 1244
Summary Burkitt's lymphoma is a highly aggressive B-cell non-Hodgkin lymphoma and is the fastest growing human tumour... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | AFRICAN CHILDREN | PLASMODIUM-FALCIPARUM | ACUTE LYMPHOBLASTIC-LEUKEMIA | B-CELL LYMPHOMAS | ACTIVE ANTIRETROVIRAL THERAPY | C-MYC | NON-HODGKINS-LYMPHOMA | EPSTEIN-BARR-VIRUS | CHILDRENS ONCOLOGY GROUP | ACUTE MALARIA | Transcriptional Activation - genetics | Prognosis | HIV Infections - epidemiology | Humans | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Child, Preschool | Infant | Burkitt Lymphoma - epidemiology | Incidence | Endemic Diseases | Malaria - epidemiology | Burkitt Lymphoma - genetics | Epstein-Barr Virus Infections - genetics | Child | Burkitt Lymphoma - drug therapy | Epstein-Barr Virus Infections - epidemiology | Poverty - statistics & numerical data | Health Services Accessibility - statistics & numerical data | Burkitt Lymphoma - virology | Cross-Sectional Studies | Epstein-Barr Virus Infections - virology | Risk Factors | Rituximab | Epstein-Barr Virus Infections - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Proto-Oncogene Proteins c-myc - genetics | Translocation, Genetic - genetics | Care and treatment | Immunocompromised host | Patient outcomes | Genetic aspects | Risk factors | Burkitt's lymphoma | Diseases | Causes of | Practice guidelines (Medicine) | Diagnosis | Low income groups | Chemotherapy | Consolidation | Malaria | Human immunodeficiency virus--HIV | Cyclin-dependent kinases | Drug therapy | Epidemiology | Cancer therapies | Cancer | Apoptosis | Tumors
Journal Article
JNCI : Journal of the National Cancer Institute, ISSN 1460-2105, 2014, Volume 106, Issue 2, p. djt378
Journal Article
Journal Article
Journal Article
Journal Article
American journal of hematology, ISSN 0361-8609, 2015, Volume 90, Issue 9, pp. 790 - 795
Journal Article
Journal Article